The Future of Cancer Screening—Guided Without Conflicts of Interest
Author:
Affiliation:
1. Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway
2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Abstract
Publisher
American Medical Association (AMA)
Subject
Internal Medicine
Link
https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2808645/jamainternal_adami_2023_vp_230011_1695921444.36005.pdf
Reference10 articles.
1. Estimated lifetime gained with cancer screening tests.;Bretthauer;JAMA Intern Med
2. Why cancer screening has never been shown to “save lives”—and what we can do about it.;Prasad;BMJ,2016
3. Full disclosure about cancer screening.;Gigerenzer;BMJ,2016
4. Cancer screening—the good, the bad, and the ugly.;Welch;JAMA Surg,2022
5. Mammography screening.;Autier;Eur J Cancer,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. When Is It Too Early To Start Prostate Cancer Screening? Reflections on the PROBASE Study Using Magnetic Resonance Imaging for Men Aged 45 Yr with Elevated Prostate-specific Antigen;European Urology;2024-02
2. Diminishing Mortality Benefit of Cancer Screening With Improvements in Treatment;JAMA Internal Medicine;2024-01-08
3. Breast cancer screening motivation and behaviours of women aged over 75 years;Psycho-Oncology;2023-12-18
4. Cancer screening: Study challenges whether six common tests save lives;BMJ;2023-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3